Last reviewed · How we verify
10% glucose solution
The 10% glucose solution, marketed by Umeå University, holds a position in the healthcare market as a widely recognized and utilized therapeutic agent. A key strength of this solution is its broad acceptance and established use, underpinned by a key composition patent that remains in effect until 2028. The primary risk to the product is the potential increase in competition once the key patent expires in 2028.
At a glance
| Generic name | 10% glucose solution |
|---|---|
| Sponsor | Umeå University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies (PHASE1)
- Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain (NA)
- Effect of Topically-applied Milrinone or Nitroglycerin on Internal Mammary Artery Free Flow (PHASE3)
- Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia. (PHASE2)
- iGlarLixi CGM Study in Chinese T2D Individuals After OADs (PHASE4)
- Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) (PHASE2)
- Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65). (PHASE3)
- Field Study on Intravenous Iloprost for Treatment of Severe Frostbite at High Altitude
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 10% glucose solution CI brief — competitive landscape report
- 10% glucose solution updates RSS · CI watch RSS
- Umeå University portfolio CI